Nicotine + Nicotine + Nicotine
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Tobacco Dependence
Conditions
Tobacco Dependence
Trial Timeline
Feb 1, 2011 → Jun 1, 2011
NCT ID
NCT01321931About Nicotine + Nicotine + Nicotine
Nicotine + Nicotine + Nicotine is a phase 1 stage product being developed by Johnson & Johnson for Tobacco Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01321931. Target conditions include Tobacco Dependence.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01321931 | Phase 1 | Completed |
| NCT01075659 | Phase 2 | Completed |
| NCT01440985 | Pre-clinical | Completed |
Competing Products
20 competing products in Tobacco Dependence